Sponsors (10)
This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Expresses the Senate’s endorsement of the United States Preventive Services Task Force (USPSTF), restates the Task Force’s mission to issue evidence-based clinical preventive service recommendations, and raises concern about reduced support from the Agency for Healthcare Research and Quality (AHRQ). It notes a recent Supreme Court decision upholding the Task Force’s constitutionality and records that a scheduled Task Force meeting (July 10, 2025) was canceled by the Secretary of Health and Human Services, while emphasizing that formal Task Force meetings are required to vote on recommendations that affect insurer coverage.
The bill preserves no-cost access to evidence-based preventive services and strengthens transparency, improving preventive care for many Americans, but raises fiscal pressures and risks slower or politicized updates to recommendations if funding or governance changes impede timely, independent reviews.
Patients — including Medicare and Medicaid beneficiaries and people with chronic conditions — keep access to A- or B-graded preventive services without cost-sharing, reducing out-of-pocket costs for screenings and preventive medications.
Patients with chronic conditions benefit from stronger, evidence-based preventive recommendations (e.g., cancer and cardiovascular screening and counseling), which can raise quality of care and reduce morbidity over time.
Patients and state governments gain greater transparency and trust in preventive recommendations through public nomination processes and conflict-of-interest rules that limit biased appointees.
Taxpayers and middle-class families may face higher federal and private healthcare costs — maintaining coverage for A/B preventive services increases insurer and government spending, which can lead to higher premiums or taxes over time.
Patients and health systems could experience delays in access to newly recommended preventive services if reduced AHRQ funding and staffing slow evidence reviews and the updating of recommendations.
Medicare and Medicaid beneficiaries and other patients could see politicized or delayed recommendations if the Secretary cancels Task Force meetings or exerts appointment/review authority, which may slow coverage decisions for preventive services.
Introduced July 29, 2025 by Angus Stanley King · Last progress July 29, 2025